Adapted from: Global NMO Training 2016 plenary presentation by Glenn Pierce
Reviewed by: Glenn Pierce
Edited by: Georghia Michael
This second module in the Treatment Products eLearning Program explains the evolution of products for the treatment of bleeding disorders, from products derived from blood to artificially produced clotting factor concentrates (CFCs) with extended half-lives (EHL). It describes how each type of product provided a breakthrough in care and the accompanying advances in safety each delivered. In addition, this module discusses pharmacological alternatives to factor replacement therapy that can reduce the need for blood transfusion and factor concentrates, and it touches upon the products used to treat von Willebrand disease. Illustrations and interactive features make this complex content easy to follow while the glossary and linked resources provide more in-depth explanations. Fun quizzes and progress checks allow the learner to assess their understanding, and point back to specific sections for re-study if necessary.
Click on the “View Resource” button above to launch the module. Click on the NEXT and PREV buttons in the bottom right corner to move forward and backward through the module, or jump to a specific section by selecting it from the Table of Contents on the bottom left. The second screen presents all the interactive features of the module and how to use them. Click Help in the upper right corner of the screen at any time to return to this screen.
Glossary terms are highlighted in yellow, look up their definitions by clicking Glossary in the top right of the screen. Full-text supplementary resources are available by clicking Resources in the top left corner. You will find these icons throughout the module, click them for interactive access to more essential information: